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EXECUTIVE SUMMARY
With recently accelerated support for the development of microbicides to prevent HIV transmission and
the urgency of the global AIDS epidemic, it is important to begin to identify strategies for introducing a
microbicide once it is proven safe and effective and is approved for use. This report presents results from
a qualitative study that explored a range of issues likely to influence microbicide introduction—positively
or negatively—at three levels: community, health service, and policy. The study identified critical issues
to be addressed in building support for microbicides and facilitating smooth introduction.
Historically, technological innovations have had varying degrees of success in introduction; some have
encountered significant obstacles that might have been avoided with more careful preparation. It is
critically important to understand gender-related, social, economic, cultural, and structural contexts before
any new innovation is introduced. This research aims to inform microbicide introduction strategies in an
effort to avoid the delays and false starts that have hindered the introduction of new health technologies in
the past.
The introduction of microbicides is likely to be complex for a number of contextual and product-related
reasons. First, microbicides, especially the first generation of microbicidal products, are likely to be
partially effective, with lower effectiveness than condoms in preventing HIV transmission. Second,
microbicides will be “user-controlled” vaginal products that require acknowledgement and discussion of
sexuality and sexual practices, issues that policy makers, providers, and users can find difficult. Finally,
by potentially providing women with more power and control over their sexual lives, microbicides may
challenge traditional gender norms. Given this range of complex issues, targeted social-science research
into the beliefs and attitudes that are likely to affect understanding, acceptance, and use could greatly
facilitate the introduction of this new technology. Such research can be used for informing policy,
identifying necessary adjustments in the service delivery context, and guiding message development and
product imaging for communities and users.
The study was conducted between September 2002 and September 2003 in Langa, a peri-urban site in the
Western Cape Province of South Africa, and at national and provincial levels. Through in-depth
interviews and focus group discussions, this study explored and identified issues that could facilitate or
undermine access to and use of microbicides. The study included a range of respondents from the three
levels of inquiry. Respondents included community members, health care providers and managers,
provincial- and national-level government officials, and representatives from national and provincial
nongovernmental organizations and health professional bodies that influence policy.

KEY FINDINGS
The need for microbicides
Respondents at all three levels expressed support for microbicide introduction. The severe effect of the
AIDS epidemic on people’s everyday lives and the urgent and desperate need for new approaches to help
curtail the spread of HIV was the most powerful argument for microbicides to emerge from the data.
The respondents conveyed an understanding and acceptance of the reality of women’s social vulnerability
to HIV infection and the limits on women’s ability to protect themselves, including the need for femaleinitiated prevention options due to widespread resistance to male condom use. Since microbicides are
expected to be mostly female-initiated and controlled, participants felt that the products could provide an
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important option in giving women the ability to protect themselves with or without their partners’
support.
The “prevention equation”—the idea that a lower-efficacy product, like microbicides, used consistently
could provide overall protection at the individual and population level better than a higher-efficacy
product, like condoms, used less consistently—generated little reaction when raised by the interviewers. It
is not certain whether this was due to the concept being unclear, or because respondents did not need
additional evidence beyond the devastating effects of the epidemic to make the case for microbicides.

Partial effectiveness
Respondents at all levels were concerned about the partial effectiveness of the first generation of
microbicides, presented as ranging from 40–70%. Despite apprehensions among a few providers and
policy-makers about promoting a partially-effective method, most saw it as a trade-off to the high need
and demand for such a product. They supported its introduction, pointing out that no method is “one
hundred percent” effective, including condoms with typical use. Additionally, many providers and policy
makers pointed out that the numerous barriers to condom use underscore the need for more acceptable
prevention alternatives such as microbicides. The concept of a “hierarchy of methods” naturally emerged
form the discussions. Some felt that microbicides should be positioned alongside male and female
condoms either as a dual method or as stand-alone products to reduce risk where other, more effective
prevention options are not feasible. The severity of the situation made women feel that it was preferable
to take some action rather than to do nothing, even if microbicides were not 100 percent effective.

Covert or overt use
Women’s lack of power in sexual relationships was cited as both a barrier and an incentive to microbicide
use. Both women and men strongly recommended partner involvement and open communication about
microbicide use, and many believed that such communication would be feasible. Other participants,
however, felt that in the context of certain relationships, covert use would be a necessary alternative
where there was a lack of trust between partners, where women lacked the power to negotiate the
method’s use, or where they feared repercussions, including violence, of raising microbicide use with
partners. Community members, service providers, and policy makers alike questioned women’s ability to
negotiate microbicide use and said that even covert use might be difficult or could result in negative
repercussions if discovered.

Condom substitution
Opinions varied about the potential impact of microbicides on condom use, specifically whether people
who successfully use condoms would be likely to use microbicides instead. Some policy-level
respondents worried that microbicide introduction could undermine condom use, particularly among
adolescents. Some male—and female—focus group participants indicated that they might, indeed, stop
using condoms in favor of microbicides. In contrast, many respondents recognized that among many
groups consistent condom use remains low, and felt that the introduction of microbicides would not
decrease condom use. Instead, they felt that microbicides could potentially provide an important
alternative for those who would not or could not use condoms.

Rape and unplanned sex
Respondents described several situations requiring a long-acting product that women could insert before
leaving the house as a routine practice in case something unexpected or unplanned happened that would
expose them to risk. Concerns about sexual violence were expressed strongly and discussed at length. In
addition to their own fears, participants in community focus group discussions frequently raised the
possibility of young children being raped. Respondents also felt microbicides would be useful when a
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woman had unplanned, but consensual, sex, or for protection in case a man attempted to infect them
intentionally. People assumed that the product would be long-acting and convenient enough to be used
daily. None of these possibilities was asked about directly or probed for; participants spontaneously raised
them in many focus groups and interviews, indicating that this could be a potentially important role for
microbicides.

“Wetness” and lubrication
Concerns emerged among respondents at all levels about “wetness,” pertaining to the added moisture that
a microbicide formulated as a gel or cream could provide during sexual intercourse. Wetness was
discussed, for the most part, from three perspectives: a) a woman’s vaginal wetness implying infidelity
(i.e. she had been with another man); b) the preference of men for a “not wet” or “dry” vagina for
increased sexual pleasure; or c) the association of wetness with sexually transmitted infections (STIs).
Men were concerned that it would be difficult to distinguish whether a woman was wet due to the
microbicide or because she had sex previously with another man, and women were anxious about being
accused of infidelity. Many referred to men’s preferences for the vagina to be dry or “not wet” (although
this was not associated with the use of drying agents), indicating that wetness associated with
microbicides could be perceived as negatively affecting sexual pleasure.

Intravaginal product use
Participants expressed wide-ranging and contradictory views about women’s experience and comfort with
the use of vaginal products. Women in focus groups said they were familiar and comfortable with using
vaginal products and were already using tampons and “vaginal creams for thrush.” Providers supported
this view, although policy-level respondents gave mixed views, some expressing concern that women
would be unfamiliar with or unwilling to use an intravaginal product.

Product characteristics
The aesthetic and physical characteristics of microbicides also were viewed as important intrinsic factors
that could hinder or facilitate microbicide use. In terms of physical properties of the product itself,
characteristics of concern included smell, messiness, stability at different temperatures without
refrigeration, duration of effectiveness, and how well the product would adhere in relation to bodily
functions (e.g., whether the microbicide would be washed away with urination). Respondents expressed
discomfort with aspects of the sample applicator shown, and suggested alternative product forms.
Respondents at various levels of inquiry differed in their views on the preferred scope of protection
against HIV, other STIs, and pregnancy. Women tended to prefer microbicides that would not prevent
pregnancy, while more men favored products that also were contraceptives, although many presented
contrasting views. Providers were keen on offering microbicides that could prevent a range of STIs in
addition to HIV and were less interested in the product’s contraceptive properties, while several policy
makers felt that a microbicide with dual protection (contraceptive and STI prevention) could facilitate use
and be a beneficial addition to family planning programs.

Potential microbicide users
Respondents thought that a wide range of people, including very young girls, youth, married and
unmarried women, older women, and men, could potentially use microbicides. Health care providers
were generally more comfortable categorizing appropriate microbicide user groups according to risk,
particularly those with a history of STIs, HIV-positive individuals, sex workers, and those unable to
negotiate condom use. Community participants and some providers suggested that youth should be the
main users and beneficiaries of a possible future microbicide, because they were the most sexually active,
did not use condoms, and were the most vulnerable to unplanned, unprotected, and coercive sex.
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However, some policy makers expressed reservations about targeting youth, citing in particular recent
gains in condom use among this group.

Need for information
Policy makers, providers, and community participants all stated that they would need information about
effectiveness, efficacy, safety, side effects, and contraindications before they would recommend
microbicides to clients or support their introduction. Given that the first microbicides will not provide
complete protection, both national and provincial level policy makers pointed out that clients must be
fully aware of the implications of partial effectiveness. They emphasized a desire to have access to
evidence from both animal and human clinical studies to determine whether microbicides were in fact
safe and effective. Respondents’ understanding of concepts such as safety, efficacy, and partial
effectiveness were often erroneous; some policy makers highlighted the need to further examine the way
in which information about these key concepts should be conveyed to potential users, policy makers, and
providers, stressing the need for simple yet comprehensive information to facilitate informed choice.

Distribution and marketing
Participants across all three levels of inquiry also felt that microbicides should be distributed widely—not
only in health clinics, such as family planning, well-baby, maternal health, and VCT centers, but also in
places where women congregate and locations that are easily accessible in the community: chemists;
supermarkets and shops where herbal medicines are obtained; local informal shops and bars; and
community-based organizations. Despite a desire for widespread access, many respondents at all levels,
concerned about safety and partial effectiveness, hesitated to endorse distribution of these products in
venues where personal counseling is not available or quality control would be difficult to ensure. In
community focus groups, men and women of all ages and socio-economic groups stressed the need for
media campaigns and for community-based sources of information to be available at such places as
churches, schools, libraries, and other community organizations.

Sustainability of supply and cost
Several policy-level respondents warned about the problems in creating demand for the product at the
community level before supplies are sustainable. Citing some experience with the female condom, they
underscored that a reliable and affordable supply needs to be in place before widespread marketing of
microbicides begins. To address these concerns, and to allow users to become familiar with the products,
some suggested a gradual introduction strategy. National and provincial policy makers, key policy
informants, and providers all stressed that microbicides should be accessible to clients and provided at
low cost or free. Some community and policy-level respondents supported the assertion of social
marketers that products distributed in the public sector or free of charge are seen as inferior to other
methods or products. Finally, a number of policy makers expressed concern about the cost to the health
system, the lack of resources throughout all levels of the health system, and the difficult decisions that
must be made among competing priorities.

DISCUSSION
A number of key results from this study—in areas such as product characteristics, condoms and condom
substitution, partner involvement versus covert use, distribution strategies, and lubrication (“wetness”)—
echo and expand upon findings of previous social science research and programmatic experience.
However, several somewhat unexpected issues emerged quite strongly, such as the widespread
understanding of women’s vulnerability and their need for alternatives like microbicides, and the broad
assumptions about microbicide use for protection in case of unplanned sex or rape. Several of these
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themes have direct implications for policy or further research related to product development and
introduction.

Support for microbicides
Consistent with the growing recognition of the need for microbicides, respondents across the range of
categories expressed strong support for product development and introduction. This interest derived from
several related underlying issues that were described frankly and eloquently. First, participants exhibited
widespread understanding and recognition of women’s vulnerability to HIV infection. Many spoke
openly—and spontaneously—about the underlying social, economic, and political factors that contribute
to women’s lack of control over sexual relations. Given the devastating impact of the HIV/AIDS
epidemic in this setting, there was a real sense of desperation among community participants, providers,
and policy makers for something that could help prevent HIV infection. Second, while respondents in all
groups felt strongly that condoms must be promoted, there was widespread recognition of the limitations
of condoms and their use. There was a strong sense that additional technologies and approaches are
urgently needed, especially those that women can initiate, and a real frustration at the relatively long
timeframe before an effective microbicide could potentially be made available.
Despite some concerns, the need and potential for microbicides resonated strongly with those interviewed
for this study. This may be attributable largely to the impact of the HIV/AIDS epidemic and the vigorous
public discourse on AIDS in South Africa; strategies for developing support for microbicides will clearly
need to be tailored to other contexts. Even with the significant support among those interviewed for this
study, participants expressed a number of concerns and uncertainties about microbicides, and an
understandable need to know more about a specific product before they would approve, recommend, or
use it. Therefore, while there seemed to be widespread general support for a product like a microbicide, a
more specific case will need to be built based on the evidence from research and characteristics of a
particular product.

Implications of introducing a partially effective product
As expected, the issue of partial effectiveness emerged as a major concern, particularly among providers
and policy makers. Discussion underscored the challenges of accurately conveying complex messages
about risk reduction and the options presented by a partially effective product. Initially, respondents
across all three categories expressed some unease about the implications of introducing microbicides as
“stand-alone” products, given that they will be less effective than condoms. Many were more comfortable
with microbicides as a complement or addition to existing prevention options, and with including them as
part of a hierarchy or method mix so that people would be able to choose from more options. A striking
element of these interviews is how providers’ and policy makers’ concerns about partial effectiveness
evolved from initial apprehension about practical and ethical implications to a more positive and
affirmative view of the role microbicides could play in reducing individual risk and population-based
incidence. This underscores some of the complexities of resistance to microbicides and suggests that
some initial concerns and assumptions may be amenable to change.

Condom substitution
Policy and provider-level respondents expressed some concern about the possibility that introducing
microbicides may lead people to switch from condoms to microbicides, undermining condom promotion
and use. Some community members confirmed this possibility, indicating that they would welcome the
availability of microbicides primarily because they would provide an alternative to condoms.
Providers and policy makers reflexively positioned condoms as the “gold standard,” although on further
reflection most acknowledged the condom’s limitations and that actual use among many groups is low.
This suggests the importance of developing policy approaches and messages for introducing microbicides
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that accurately reflect actual condom use and the impact of condoms in HIV risk-reduction, rather than a
theoretical ideal. In addition, while acknowledging that condoms are unpopular, participants rarely
discussed perceptions or assumptions about the particular circumstances and types of relationships in
which condoms or microbicides would be used.
Given growing understanding about how relationships and other circumstances influence condom use, it
would be useful to explicitly explore these themes with respect to microbicides. Finally, concerns about
condom substitution will likely shift along with any changes in condom use that may occur: if condom
use increases before microbicides are introduced, condom substitution may become more of a concern.
Given the long timeframe for microbicide development and introduction, this issue will need to be
continually revisited in light of any changes in patterns of condom use.

Rape and unplanned consensual sex
One of the primary unexpected findings was the degree to which respondents across levels—especially
community members—assumed that an important application for microbicides would be use by women to
provide protection in case of rape. Rape is widespread in South Africa and has been extensively discussed
and debated in the public arena, contributing to an acute awareness of the problem and a perception that it
constitutes an immediate risk in women’s daily lives. Women also discussed the utility of microbicides in
the case of unplanned consensual sex. Both of these uses imply an assumption that women would be able
to apply a microbicide as part of a daily routine. This would necessitate that a microbicide have a
relatively long duration of action, and that it would be both affordable and convenient enough to be used
daily. This has important implications for microbicide development and for how microbicides could be
introduced or marketed.

Wetness, lubrication, and intravaginal practices
The issue of “wetness” resonated strongly with study participants as a serious concern. It has been an
ongoing concern in the microbicide field that the lubricating properties of current gel formulations could
compromise acceptability and widespread use of microbicides. Respondents across categories had
different perceptions about how important added lubrication might be in hampering microbicide
acceptability and use. Consistent with recent reviews of this issue, the extensive discussions and wideranging interpretations of lubrication in this study underscore the need to examine the actual meanings
associated with wetness and lubrication in different settings, rather than relying on assumptions about
practices and preferences. Similarly, the different perceptions of policy makers and community members
with regard to women’s comfort with intravaginal product use point to the importance of examining
actual experience rather than assumptions. Beliefs and assertions by policy makers or providers that
“women won’t use them [microbicides]” because they are inserted vaginally could erroneously inhibit
support for microbicides, even in settings where women regularly use vaginal products.

Positioning and distribution strategies
Findings from this study suggest that microbicides could be positioned for a wide range of potential users.
While in other settings people often assume that “high risk groups,” particularly sex workers, would be
the most likely and appropriate users, respondents in this study suggested a much wider range, including
children (in the case of rape) and “older” married women. It was widely assumed that younger, unmarried
women, including youth, would be important users of microbicides; however, while this assumption was
strongly supported by providers and community members, policy makers were less supportive of
targeting youth due to concerns about potentially undermining recent gains in condom use and thereby
increasing risk. There was strikingly little stigma associated with microbicides or the people who might
use them, and a real sense that microbicides would be “mainstream” products.
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Suggested distribution strategies underscored the tension between making microbicides widely available
in a range of clinical and non-clinical outlets and the challenges of conveying complex messages about
risk reduction and partial effectiveness, which imply the need to control distribution to assure counseling
and fully informed choice. Community members suggested a wide range of potential distribution points
and strategies and cautioned against “medicalization” of the product. On the other hand, given that the
first microbicides might be only partially effective, policy makers, providers, and community members
hesitated to endorse widespread distribution without adequate counseling or information. There was some
support for a compromise approach where products could be introduced first through a more formal
clinical setting; then, once the public is familiar with the products’ attributes and has some experience
using them, more widespread availability could be phased in over time. In general, there was a strong
sense that the best approach to positioning and marketing microbicides would be to build on strong,
affirmative messages that would associate the product with a healthy, dynamic, positive, and modern
lifestyle.

RECOMMENDATIONS
The recommendations presented below have been selected to highlight some of the less expected findings
and areas requiring careful analysis in other geographical, social, and epidemiological contexts.

Making the case for microbicides
"

“Make the case” for microbicides based on specific context: Further research in other
geographical and epidemiological settings is needed to determine the best approach to “making
the case” for microbicides. In this study, there appeared to be little need to convince people of the
necessity for a product like microbicides. The broad recognition of the need for microbicides
found in this study may not carry over to other settings where such issues are more hushed or
stigmatized, where women’s vulnerability is not as well recognized, where public discourse about
AIDS and microbicides is less evident, and where cultural differences place greater restrictions on
open discussion of sexual behaviors and practices.

"

Communicate the rationale: Efforts to evaluate the acceptability of microbicides at the provider
and policy levels will require dialogue and probing beyond immediate responses. Likewise,
communicating the rationale behind microbicides will require more than simple messages.
Despite broad support for microbicide introduction found in this study, initial responses were
more mixed and muted. Opinions changed when people talked through the issues to arrive at their
own conclusions, a finding that points to the value of qualitative research for in-depth exploration
of issues. These findings also suggest the need for advocacy and introduction strategies to assure
adequate dialogue.

"

Understand how the “prevention equation” can be used: Further investigation will be needed
to determine how the prevention equation is understood, and whether and how it could help to
make the case for microbicides. It did not appear to be particularly important in convincing policy
makers of the value of even partially effective microbicides in this context. However, this may
differ in settings where the AIDS epidemic has not had as substantial an impact, and were
microbicides may not be as readily accepted and supported.

"

Use information on intravaginal practices to counter erroneous assumptions: Assertions that
women will not use intravaginal products may not hold true, as shown in this study. Introduction
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and advocacy efforts may benefit from local data about actual use of intravaginal products to
counter erroneous assertions that could undermine introduction efforts.

Developing introduction strategies
"

Balance broad access with the need for counseling and informed choice: The possibility of
using distribution channels outside of the health sector, or outside of clinical service delivery,
should be further explored in preparing for introduction. It will be important to balance interest in
assuring broad access with the need for careful counseling, particularly given partial effectiveness
and the attendant hierarchical approach.

"

Address provider information and training needs: To assure support from providers and
providers’ participation in introducing microbicides, strategies must pay careful attention to
providers’ information and training needs. Providers, who could be pivotal in influencing
microbicide use, will need in-depth information on issues such as side effects and results of
clinical studies, and training in order to feel comfortable recommending microbicides. They also
will need support in formulating comprehensive yet simple counseling messages that allow
clients to make informed choices. Although most providers in this study would likely support
microbicides given adequate information, providers in other contexts may not be as receptive.

"

Market for use with or without a partner’s knowledge: Marketing and introduction strategies
should take into account the need for both covert and overt use of microbicides. This study
clearly demonstrated the desire by both women and men to communicate about microbicide use;
however, respondents also recognized that many circumstances would require use without a
partner’s knowledge, and they noted the benefits of having a method that could not be detected.

"

Consider youth as a potential target group for microbicides: Youth need to be seriously
considered in clinical studies, introduction strategies, and further research as a potential user
group for microbicides. Young people were spontaneously and consistently identified by various
study participants as among the primary potential users of microbicides. The results point to the
need to develop strategies that actively facilitate access and use by youth in South Africa while
addressing some policy-makers’ concerns about targeting youth. In different settings, even with
similar needs, young people’s access to sexual and reproductive health services may be more
constrained, and receptivity to them as a user group may differ.

"

Ensure a balance of supply and demand: Reliable supply and delivery systems must be in
place before demand is created for a product. This is particularly important during the critical and
sensitive introduction and scale-up stages. Although in this study only a few respondents reflected
a broad distrust of “the system,” introducing a product and failing to meet demand could
potentially exacerbate such distrust, which could slow or halt introduction efforts.

"

Enlist multisectoral support for introduction: Given the complicated nature of microbicides
and concerns around partial effectiveness, enlisting the support of broad segments of society is
likely to be critical. Several policy makers, policy influentials, and community key informants in
this study stressed the importance of enlisting the support of individuals and organizations inside
and outside of the health sector. The support of community groups, churches, labor unions, and
others may be essential to “counter the fear of the unknown” that may come with the introduction
of a new product.
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"

Address diverse needs: It will be important to determine the possibilities for different
microbicide products to meet varying needs and to continually reassess these as new methods
with different characteristics become available. This research suggests interest in both free and
low-cost products, the potential for use with or without a partner’s knowledge, and appeal to
different user groups, including married or unmarried people, youth, and sex workers. It also
suggests the need for use under varying circumstances, such as daily routine use in case of
unanticipated sex, and use in specific situations or with specific partners. Product characteristics
such as contraceptive properties and formulations (gel, suppository, film, etc) could affect the
range of potential market segments and needs.

Further research
"

Use qualitative research to understand the complexities of perceptions about microbicides,
and to allow new ideas to emerge: Further targeted, qualitative research designed to allow
emergence of new ideas would be valuable to inform introduction strategies and to better
understand the potential facilitating factors and barriers to microbicide use. In this research, effort
was made to identify critical issues up-front based on previous research, review of the literature,
and evolving discourse in the microbicide field. Nevertheless, several important issues that had
not been anticipated emerged from the research. For example, the prevalent notion of routine
microbicide use as a response to the threat of rape or sexual coercion, the notion that microbicides
would be useful to put in “before you go out” in case of unplanned sex, and the importance of
youth as a primary user group all emerged quite strongly from the data.

"

Understand the meanings and implications of “wetness”: Further research is needed to better
understand how notions of vaginal “wetness” may impact the introduction of microbicides in this
and other settings. “Wetness” emerged as a major concern, though respondents ascribed a variety
of meanings to it (“wetness” signifies infidelity, reduces sexual pleasure, is symptomatic of an
STI) and the research did not affirm a prevailing belief and concern among prevention and
microbicide advocates that “dry sex” is idealized. Little is known about whether these same
concerns would apply in other settings, and their implications for product development,
marketing strategies, and education and counseling approaches.

"

Investigate potential stigma associated with microbicides: The implications of stigma for
microbicide introduction strategies in diverse settings is particularly important in considering
distribution channels and marketing efforts. Although stigma against the product itself or against
those who might need the product did not emerge in this research as a major issue, this may be
quite different in other settings.

"

Develop and test approaches to explaining partial effectiveness: Further research will be
needed to determine approaches to explaining the meaning and implications of partial
effectiveness. Partial effectiveness was clearly a major concern among all groups interviewed,
and participants in this study varied widely in their understanding of the concept. Determining
approaches to explaining concepts such as partial effectiveness for different audiences will be
useful to ongoing research, advocacy, and ultimately, introduction efforts.

"

Investigate the effectiveness and implications of microbicide use by HIV+ women: Given the
growing population of HIV+ people in South Africa and elsewhere, further consideration needs to
be given to the reproductive and other health needs of this group. This is particularly important in
the context of more widespread availability of anti-retroviral treatment in South Africa and
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elsewhere and in the light of possible interactions between other contraceptive methods such as
hormonal contraceptives for women, for example.
The challenges facing microbicide introduction are complex, as the findings of this study demonstrate,
and respondent views have clearly been influenced by the sense of urgency and desperation in face of the
devastating impact of the HIV/AIDS epidemic in South Africa. This study aimed to gain some
understanding of the barriers and facilitating factors to microbicide introduction in the South African
context. For some issues, we have a better understanding of how they are perceived, and the nature of
concerns around them. Other issues have newly emerged from this research. Many will require further
investigation and consideration in other epidemiological and socio-cultural settings. Some will prove to
be more broadly applicable, and others are more specific to the local or national context. Successful and
rapid introduction of microbicides, once they are approved, will clearly require further research and
careful preparation.
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DEFINITIONS AND KEY TERMS
Microbicides: A generic term for agents that can block, kill, or immobilize dangerous pathogens. These
products, which are still under development, may offer the possibility for women (and men) to protect
themselves from vaginal and rectal transmission of HIV and, potentially, other STIs. Microbicides will be
used intravaginally and may be available in several forms (e.g., as a gel, suppository or film. It is also
possible that they will be used rectally.
Partial Effectiveness: Refers to estimates of effectiveness of first-generation products ranging from 40
to 70 percent. It is anticipated that the effectiveness of initial microbicide products will be considerably
lower than the effectiveness of condoms with perfect use (98%).
Prevention Equation: Refers to the notion that a lower-efficacy product used consistently could have a
greater impact on reducing infection at the individual and population level than a higher-efficacy product
that is used less consistently. One of the premises for microbicide use has been that condoms, while
highly effective when used “perfectly,” are often used incorrectly or not at all because they can be
difficult to use and are perceived as reducing sexual pleasure. Microbicides may be used more
consistently if they are easier to use, perceived as interfering less with sexual pleasure, and their use can
be initiated by women.
Condom Substitution/Migration: Refers to the concern that people who successfully use condoms
might use microbicides instead, which could lower their overall level of protection.
Hierarchy of Methods: Refers to the offer of a range of methods by level of effectiveness, the risks
and benefits offered by each method clearly identified. For example, if partially-effective microbicides
were introduced into an HIV prevention program, a message about prevention technologies would be:
“Condoms and microbicides used together offer the best protection against HIV. If you can’t use both
products, you should use male latex condoms every time you have sex. If you can’t use male condoms,
female condoms offer the next-best protection. If you can’t use condoms, microbicides used alone could
significantly reduce your risk of HIV infection.”
Method Mix: Refers to the range of HIV/STI and pregnancy prevention methods or products available
within a given program or service delivery setting.
Dual Protection: Refers to the prevention of both pregnancy and HIV/STIs through any of the
following: use of a single product that prevents both (e.g., condoms); use of two methods (dual-method
use, one for contraception and one for disease prevention); mutual monogamy with an uninfected partner
using a contraceptive method; the avoidance of risky sex; or a range of other risk-reduction strategies.
Although this term sometimes refers to protection against both HIV and other STIs, it is not used that way
in this report.
Dual Methods: Refers to the use of two methods simultaneously (e.g. condoms and pills, or condoms
and microbicides) to prevent HIV and pregnancy or to increase the effectiveness of an HIV prevention or
pregnancy prevention method.
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